Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
373 results
D1.01 - Anaphylaxis After Crayfish Consumption with Strong Anisakis simplex Sensitization
D1.111 - Tezepelumab reduces in patients with severe allergic asthma and rhinoconjunctivitis not only bronchial but also nasal and conjunctival symptoms – results from an exposure chamber study
D1.112 - ILC2 Expansion as a Biomarker of Suboptimal Response to Dupilumab in Severe Asthma: Findings from the PRISM Study
D1.119 - Care pathways and systemic steroid (over)use in chronic rhinosinusitis with nasal polyps (CRSwNP) in Germany
D1.120 - Genetic Associations with Asthma in the Kazakh Population: A Case–Control Study
D1.125 - Smartphone-Based Asthma Monitoring Using an Audio-Assisted Mouthpiece and STFT-VGG19 Deep Learning Model
D1.132 - Novel CD8+CD122+ Regulatory T Cells Induced by B Cells Suppress T helper 2 Response and Attenuate Eosinophilic Infiltration in Allergic Asthma
D1.158 - Clinical and Functional Outcomes of Biological Therapy Switching in Severe Asthma: A Real-Life Retrospective Study
D1.180 - Hidden fragility behind optimal ACT score: identifying silent-risk phenotypes through clinical-biological dissociation
D1.195 - Fc-Engagers as a targeted approach for antigen-specific immune inhibition in HDM allergy
D1.197 - Safety and efficacy of a modified one-day ultra-rush protocol for the induction of Hymenoptera venom immunotherapy in patients with anaphylaxis in Switzerland
D1.202 - Comparison of 2 different medication scores for the calculation of the Combined Symptom and Medication Score – EAACI versus paediatric medication in Germany
D1.203 - Prospective study to investigate the symptom profile and medication consumption of patients with seasonal allergic rhinitis/rhinoconjunctivitis who are interested in allergen-specific immunotherapy
D1.207 - Molecular Patterns and Age-Related Evolution of Pollen Sensitization in Children
D1.215 - Safety of subcutaneous immunotherapy with purified native protein Alt a 1, a major allergen of Alternaria alternata: 7-year real-world data
D1.217 - Reduction in healthcare resource utilization in pediatric patients treated with 300 IR liquid SLIT: a real‑world subanalysis from Spain and Italy
D1.242 - Early-Life Dietary Diversity and the Risk of Atopic Dermatitis: A Nationwide Population-Based Cohort Study
D1.27 - Delayed Hypersensitivity Reactions to Iodinated Contrast Media: Diagnostic Outcomes and Alternative Selection
D1.281 - Development of a Peanut-Specific Human Mast Cell Assay for Screening Probiotics and other Nutritional Components with Anti-Allergic Potential
D1.306 - Cold-induced urticaria: Phenotypic characterization and risk factors for cold-induced anaphylaxis
Pagination
Current page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
…
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download